Search research articles
Contact Us
Filters
Showing results (161-170 of 183) with videos related to
Page
of 19
Sort By:
Cancer Management and Research
|
March 19, 2019
Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
Kun-Chun Chiang, Sheng-Teng Huang, Ren-Chin Wu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2016
EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells
Chun-Yu Liu, Tzu-Ting Huang, Chun-Teng Huang, et al.
Journal for Immunotherapy of Cancer
|
January 27, 2025
Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma
Shin-Yi Chung, Yi-Chen Yeh, Chien-Jung Huang, et al.
The Oncologist
|
December 20, 2019
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas
Ming-Huang Chen, Wen-Chi Chou, Chin-Fu Hsiao, et al.
Cell Cycle (Georgetown, Tex.)
|
September 22, 2017
SKAP2 regulates Arp2/3 complex for actin-mediated asymmetric cytokinesis by interacting with WAVE2 in mouse oocytes
Shu-Wen He, Bai-Hui Xu, Yu Liu, et al.
The Oncologist
|
April 22, 2025
Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors
Nai-Jung Chiang, Jih-Hsiang Lee, Ming-Huang Chen, et al.
International Journal of Cancer
|
November 29, 2014
Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth
Sheng-Ming Wu, Wan-Li Cheng, Chia-Jung Liao, et al.
Oncotarget
|
January 27, 2018
Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients
Chun-Nan Yeh, Yu-Chan Chang, Yeu Su, et al.
International Journal of Cancer
|
January 28, 2016
Clinical significance of circulating plasma DNA in gastric cancer
Wen-Liang Fang, Yuan-Tzu Lan, Kuo-Hung Huang, et al.
Molecular & Cellular Proteomics : MCP
|
February 12, 2013
Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma
Chia-Hung Liu, Tzu-Chi Chen, Gar-Yang Chau, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 183) with videos related to
Sort By:
Page
of 19
Cancer Management and Research
|
March 19, 2019
Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
Kun-Chun Chiang, Sheng-Teng Huang, Ren-Chin Wu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2016
EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells
Chun-Yu Liu, Tzu-Ting Huang, Chun-Teng Huang, et al.
Journal for Immunotherapy of Cancer
|
January 27, 2025
Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma
Shin-Yi Chung, Yi-Chen Yeh, Chien-Jung Huang, et al.
The Oncologist
|
December 20, 2019
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas
Ming-Huang Chen, Wen-Chi Chou, Chin-Fu Hsiao, et al.
Cell Cycle (Georgetown, Tex.)
|
September 22, 2017
SKAP2 regulates Arp2/3 complex for actin-mediated asymmetric cytokinesis by interacting with WAVE2 in mouse oocytes
Shu-Wen He, Bai-Hui Xu, Yu Liu, et al.
The Oncologist
|
April 22, 2025
Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors
Nai-Jung Chiang, Jih-Hsiang Lee, Ming-Huang Chen, et al.
International Journal of Cancer
|
November 29, 2014
Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth
Sheng-Ming Wu, Wan-Li Cheng, Chia-Jung Liao, et al.
Oncotarget
|
January 27, 2018
Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients
Chun-Nan Yeh, Yu-Chan Chang, Yeu Su, et al.
International Journal of Cancer
|
January 28, 2016
Clinical significance of circulating plasma DNA in gastric cancer
Wen-Liang Fang, Yuan-Tzu Lan, Kuo-Hung Huang, et al.
Molecular & Cellular Proteomics : MCP
|
February 12, 2013
Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma
Chia-Hung Liu, Tzu-Chi Chen, Gar-Yang Chau, et al.
Page
of 19